These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2196085)

  • 1. Renal function and blood pressure in psoriatic patients treated with cyclosporin A.
    Feutren G; Abeywickrama K; Friend D; von Graffenried B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():57-69. PubMed ID: 2196085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():95-100. PubMed ID: 2369573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis.
    Feutren G; Friend D; Timonen P; Barnes A; Laburte C
    Br J Dermatol; 1990 Jun; 122 Suppl 36():85-93. PubMed ID: 2369572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose cyclosporin A in severe psoriasis. A double-blind study.
    Van Joost T; Bos JD; Heule F; Meinardi MM
    Br J Dermatol; 1988 Feb; 118(2):183-90. PubMed ID: 3280000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of side-effects of medium- and low-dose cyclosporin maintenance therapy in psoriasis.
    de Rie MA; Meinardi MM; Bos JD
    Br J Dermatol; 1990 Sep; 123(3):347-53. PubMed ID: 2206973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis.
    Erkko P; Granlund H; Remitz A; Rosen K; Mobacken H; Lindelöf B; Reitamo S
    Br J Dermatol; 1998 Dec; 139(6):997-1004. PubMed ID: 9990362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A in atopic dermatitis.
    Ross JS; Camp RD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():41-5. PubMed ID: 2196083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands.
    Meinardi MM; de Rie MA; Bos JD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():27-31. PubMed ID: 2196081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis.
    Powles AV; Cook T; Hulme B; Baker BS; Lewis HM; Thomas E; Valdimarsson H; Fry L
    Br J Dermatol; 1993 Feb; 128(2):159-65. PubMed ID: 8457449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four years of experience with cyclosporin A for psoriasis.
    Powles AV; Baker BS; Valdimarsson H; Hulme B; Fry L
    Br J Dermatol; 1990 Jun; 122 Suppl 36():13-9. PubMed ID: 2369568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
    Zachariae H; Steen Olsen T
    Clin Nephrol; 1995 Mar; 43(3):154-8. PubMed ID: 7774070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function after long-term low-dose cyclosporin for psoriasis.
    Powles AV; Carmichael D; Hulme B; Thomas E; McFadden J; Baker B; Valdimarsson H; Fry L
    Br J Dermatol; 1990 May; 122(5):665-9. PubMed ID: 2112945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders.
    Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ
    Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does fish oil protect renal function in cyclosporin-treated psoriasis patients?
    Stoof TJ; Korstanje MJ; Bilo HJ; Starink TM; Hulsmans RF; Donker AJ
    J Intern Med; 1989 Dec; 226(6):437-41. PubMed ID: 2489230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin-associated nephropathy in patients with autoimmune diseases.
    Mihatsch MJ; Bach JF; Coovadia HM; Førre O; Moutsopoulos HM; Drosos AA; Siamopoulos KC; Noël LH; Ramsaroop R; Hällgren R
    Klin Wochenschr; 1988 Jan; 66(2):43-7. PubMed ID: 3347004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.